{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:45:16Z","timestamp":1790660716941,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011265","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000}}],"reference-count":45,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011265.pub2","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T04:47:39Z","timestamp":1560574059000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy"],"prefix":"10.1002","volume":"2019","author":[{"given":"Luiz CSP","family":"Rolim","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Internal Medicine; Rua Borges Lagoa, 1065\/110 S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina MK","family":"da Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald LG","family":"Flumignan","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Surgery, Division of Vascular and Endovascular Surgery; Rua Borges Lagoa, 754 S\u00e3o Paulo SP Brazil 04038-001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio M","family":"Abreu","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine; Anaesthesiology and Critical Care Medicine; 333 Cedar Street, TMP 3 P.O. Box 208051 New Haven CT USA 06520-8051"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio A","family":"Dib","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Medicine \/ Endocrinology; Rua Pedro de Toledo, 910 S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD011265.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00126839-200203040-00001","article-title":"Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study","volume":"3","author":"Grandis","year":"2002","journal-title":"Drugs in R&D"},{"issue":"5","key":"10.1002\/14651858.CD011265.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jdi.12493","article-title":"Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: a multicenter, randomised, double-blind, controlled trial","volume":"7","author":"Li","year":"2016","journal-title":"Journal of Diabetes Investigation"},{"issue":"1","key":"10.1002\/14651858.CD011265.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD011265.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011265.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"A556; Abstract","DOI":"10.1007\/BF03162081","article-title":"Effect of treatment with acetyl-l-carnitine on diabetic foot ulceration in patients with peripheral neuropathy: a 1 year prospective multi-centre study","volume":"40","author":"Abbott","year":"1997","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02369363","article-title":"AcetyI-L-carnitine for symptomatic diabetic neuropathy","volume":"38","author":"Quatraro","year":"1995","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD011265.pub2-BIB0007|cit7","first-page":"76","article-title":"Acetyl-L-carnitine. Monograph","volume":"15","year":"2010","journal-title":"Alternative Medicine Review"},{"issue":"4","key":"10.1002\/14651858.CD011265.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Boulton AJM NICE guidelines for the management of painful diabetic neuropathy Practical Diabetes International 2010 215 6 10.1002\/pdi.1486","DOI":"10.1002\/pdi.1486"},{"issue":"20","key":"10.1002\/14651858.CD011265.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline. Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011265.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","author":"Callaghan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011265.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3945\/ajcn.113.062802","article-title":"L-carnitine supplementation for adults with end-stage kidney disease requiring maintenance haemodialysis: a systematic review and meta-analysis","volume":"99","author":"Chen","year":"2014","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD011265.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment","volume":"11","author":"Cruccu","year":"2004","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD011265.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2004.01271.x","article-title":"Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes","volume":"21","author":"Daousi","year":"2004","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0016|cit16","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD011265.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD011265.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880110106","article-title":"Detection, characterization, and staging of polyneuropathy: assessed in diabetics","volume":"11","author":"Dyck","year":"1988","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD011265.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011265.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0021|cit21","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"7414","key":"10.1002\/14651858.CD011265.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0023|cit23","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0024|cit24","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD011265.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1665-2681(19)31323-7","article-title":"Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine","volume":"12","author":"Jiang","year":"2013","journal-title":"Annals of Hepatolology"},{"issue":"3","key":"10.1002\/14651858.CD011265.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e0119479","DOI":"10.1371\/journal.pone.0119479","article-title":"Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0027|cit27","unstructured":"Cochrane Pain Palliative & Supportive Care Review Group Authoring or assessing a Cochrane Protocol, Review, or Review Update for the PaPaS Review Group, 2011 Available from: papas.cochrane.org\/sites\/papas.cochrane.org\/files\/public\/uploads\/L%20-%20PaPaSAuthor%26RefereeGuidance.pdf"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1320.003","article-title":"Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism","volume":"1033","author":"Rebouche","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0029|cit29","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"7","key":"10.1002\/14651858.CD011265.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1590\/S0004-27302009000700005","article-title":"Clinical heterogeneity and coexistence of diabetic neuropathies: difference and similarities between types 1 and 2 diabetes mellitus","volume":"53","author":"Rolim","year":"2009","journal-title":"Arquivos Brasileiro Endocrinologia e Metabologia"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fneur.2017.00285","article-title":"A systematic review of treatment of painful diabetic neuropathy by pain phenotype versus treatment based on medical comorbidities","volume":"8","author":"Rolim","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011265.pub2-BIB0032|cit32","first-page":"157","article-title":"L-carnitine and acetyl-L-carnitine in human nerves from normal and diabetic subjects","volume":"1","author":"Scarpini","year":"1996","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0033|cit33","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Akl E on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group Chapter 11: Completing \u2018Summary of findings\u2019 tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0034|cit34","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Akl E Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011265.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200721001-00003","article-title":"Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data","volume":"21","author":"Sima","year":"2007","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1002\/14651858.CD011265.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD011265.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eurger.2017.01.002","article-title":"Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis","volume":"8","author":"Veronese","year":"2017","journal-title":"European Geriatric Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011265.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0033-1333688","article-title":"Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis","volume":"121","author":"Vidal-Casariego","year":"2013","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"issue":"9","key":"10.1002\/14651858.CD011265.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/diacare.26.9.2549","article-title":"The development and validation of a neuropathy and foot ulcer-specific quality of life instrument","volume":"26","author":"Vileikyte","year":"2003","journal-title":"Diabetes Care"},{"issue":"5-6","key":"10.1002\/14651858.CD011265.pub2-BIB0040|cit40","first-page":"247","article-title":"The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction","volume":"12","author":"Williamson","year":"1992","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"7610","key":"10.1002\/14651858.CD011265.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.39213.565972.AE","article-title":"Effects of treatments for symptoms of painful diabetic neuropathy: systematic review","volume":"335","author":"Wong","year":"2007","journal-title":"BMJ (Clinical research ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011265.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011265.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.2337\/dc09-S350","article-title":"Painful diabetic neuropathy: advantage of novel drugs over old drugs?","volume":"32","author":"Ziegler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD011265.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.irn.2016.03.007","article-title":"Sensory neurodegeneration in diabetes: beyond glucotoxicity","volume":"127","author":"Zochodne","year":"2016","journal-title":"International Review of Neurobiology"},{"issue":"8","key":"10.1002\/14651858.CD011265.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011265","article-title":"Acetyl-L-carnitine for the treatment of diabetic polyneuropathy","author":"Rolim","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011265.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T03:47:20Z","timestamp":1686628040000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011265.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011265.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}